New stock news | Shengsheng Cold Chain once again submits an application to the Hong Kong Stock Exchange, China's largest pharmaceutical and life science temperature-controlled supply chain service provider.

According to the Securities Times APP, it was learned that on July 22, the Hong Kong Stock Exchange disclosed that Shanghai Shengsheng Pharmaceutical Cold Chain Technology Co., Ltd. (referred to as Shengsheng Cold Chain) has submitted an application for listing on the main board of the Hong Kong Stock Exchange, with China International Capital Corporation Limited and Guojin Securities (Hong Kong) as its joint sponsors. The company had previously submitted an application to the Hong Kong Stock Exchange on January 13, 2026.